Pfizer moves most of its creative duties to Publicis from IPG
The move comes nearly a year after IPG was awarded Pfizer’s creative business.#ipg #pfizer (Source: Reuters: Health)
Source: Reuters: Health - March 27, 2024 Category: Consumer Health News Source Type: news
Boots to offer Covid vaccines in England for nearly £100 a jab
Pharmacy to offer Pfizer/BioNTech vaccine to those not eligible for NHS booster shot from next weekBoots is to offer Covid vaccinations for almost £100 a shot, making it the latest provider to sell the jabs to those not eligible for a booster through the NHS.The company has confirmed it will offer the Pfizer/BioNTech vaccine to healthy customers in England aged 12 and over from next week, at a cost of £98.95 a jab.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - March 26, 2024 Category: Science Authors: Nicola Davis Science correspondent Tags: Vaccines and immunisation Boots Business Retail industry Health Society Coronavirus Science Infectious diseases Source Type: news
Boots to start selling Covid vaccines privately... at almost £100 a pop! Huge shake-up of jab roll-out sees chemists offer top-up doses to all over-12s
Under a huge shake-up to the scheme, from April 1 the high street chain will sell single-dose Pfizer vaccines at 52 stores in England, at an eye-watering cost of £98.95. (Source: the Mail online | Health)
Source: the Mail online | Health - March 26, 2024 Category: Consumer Health News Source Type: news
3 Ultra-High-Yield Dividend Stocks That Could Realistically Double Your Money by 2030
Double your money in a short time. Few investors would walk away from such an opportunity. Of course, there's no guarantee that any investment will allow you to double your money. Risk comes joined at the hip with potential rewards. However, achieving 100% returns in the next six and a half years…#arescapital #bdc #epd #midstream #pfe #pfizer #keithspeights #motleyfool #realisticallydouble (Source: Reuters: Health)
Source: Reuters: Health - March 25, 2024 Category: Consumer Health News Source Type: news
Is Pfizer the Best Dividend Stock for You?
If a dividend stock is struggling and falling in value, that pushes its yield up. This happens because while you are getting the same dividend, it is now costing you less money to acquire it. As long as the dividend remains sustainable, buying a dividend stock on a dip in price or near a low can…#pharma #pfe #pfizer #seagen #eliquis #vyndaqel #xeljanz #davidjagielski #motleyfool (Source: Reuters: Health)
Source: Reuters: Health - March 21, 2024 Category: Consumer Health News Source Type: news
As several probes target Brazil ’s Bolsonaro, his pandemic decisions are catching up to him
As Brazilian President Jair Bolsonaro’s term wound down in the final days of December 2022, he had decided to skip the ritual of handing over the presidential sash to his successor, and instead made plans to travel abroad. But there was a problem, according to a Federal Police indictment unveiled…#brazilian #jairbolsonaro #maurocid #brazil #fábioalvarezshor #supremecourt #zilancosta #capitol #brazilians #pfizer (Source: Reuters: Health)
Source: Reuters: Health - March 20, 2024 Category: Consumer Health News Source Type: news
After earnings plunge, BioNTech pins hopes on cancer drug launches
Germany's BioNTech, whose COVID-19 vaccine in partnership with Pfizer was widely used during the pandemic, reported on Wednesday a plunge in 2023 revenue and earnings as its focus shifts towards cancer drug development. The Mainz-based company posted revenues of 3.819 billion euros ($4.14…#pfizer #partnerpfizer (Source: Reuters: Health)
Source: Reuters: Health - March 20, 2024 Category: Consumer Health News Source Type: news
BioNTech shifts focus toward cancer drug development after earnings, revenue plunge
Germany’s BioNTech BNTX-Q, whose COVID-19 vaccine in partnership with Pfizer PFE-N was widely used during the pandemic, reported on Wednesday a plunge in 2023 revenue and earnings as its focus shifts towards cancer drug development. The Mainz-based company posted revenues of €3.819-billion…#bntx #pfizerpfen #partnerpfizer (Source: Reuters: Health)
Source: Reuters: Health - March 20, 2024 Category: Consumer Health News Source Type: news
Pfizer offloads $3.9 billion stake in Sensodyne-maker Haleon
Haleon said on Tuesday top shareholder Pfizer offloaded a roughly $3.9 billion stake in the consumer healthcare firm, bringing down its holding in the British company to 22.6%. Pfizer previously held a 32% stake, followed by second-largest shareholder GSK which has a 4.2% holding. This is Pfizer's…#haleon #pfizer #gsk (Source: Reuters: Health)
Source: Reuters: Health - March 19, 2024 Category: Consumer Health News Source Type: news
Pfizer Sells £3 Billion of Shares in Sensodyne Maker Haleon
(Source: Reuters: Health)
Source: Reuters: Health - March 19, 2024 Category: Consumer Health News Source Type: news
Pfizer To Cut Stake In Sensodyne Toothpaste-Maker Haleon, Potentially Worth £2B
Pfizer Inc PFE plans to slash its stake to approximately 24% in Consumer healthcare giant Haleon Plc HLN This move follows Pfizer’s earlier announcement that it will gradually divest its ownership in Haleon. The offer price per share is set to be disclosed around March 19, after a book-building…#pfizerincpfe #haleonplc #pfizer #haleon #pfizers #gskplcs #gsk #hln #pfe (Source: Reuters: Health)
Source: Reuters: Health - March 18, 2024 Category: Consumer Health News Source Type: news
Pfizer Is Selling a Chunk of Its Haleon Stock. It ’s a $3 Billion Windfall
(Source: Reuters: Health)
Source: Reuters: Health - March 18, 2024 Category: Consumer Health News Source Type: news
Pfizer to cut stake in Sensodyne toothpaste-maker Haleon to 24%
FILE PHOTO: The company logo for Haleon and the trading info is displayed on a screen on the floor of the NYSE in New York (Reuters) -Consumer healthcare firm Haleon said on Monday that U.S. drugmaker Pfizer will sell down its stake in the company to about 24%. Pfizer, which currently holds a 32%…#haleon #pfizer #gsk (Source: Reuters: Health)
Source: Reuters: Health - March 18, 2024 Category: Consumer Health News Source Type: news
Pfizer Plans to Sell About £2 Billion of Shares in Haleon
(Source: Reuters: Health)
Source: Reuters: Health - March 18, 2024 Category: Consumer Health News Source Type: news
Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?
Two companies stand at the center of the obesity drug market right now. Novo Nordisk continues to rake in money from its weight-loss drug Wegovy (and from off-label usage of its type 2 diabetes drug Ozempic.) Eli Lilly is hot on Novo Nordisk's heels with its new obesity drug Zepbound. Pfizer…#novonordisk #elililly #pfe #lilly #pf07976016 #danuglipron #pfizer #nash #vikingtherapeutics #seagen (Source: Reuters: Health)
Source: Reuters: Health - March 15, 2024 Category: Consumer Health News Source Type: news
